CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,587 | -16.6% | 368,910 | 0.0% | 0.12% | -25.3% |
| Q2 2023 | $416,868 | -11.0% | 368,910 | 0.0% | 0.16% | -12.9% |
| Q1 2023 | $468,516 | +67.9% | 368,910 | 0.0% | 0.19% | +95.8% |
| Q4 2022 | $279,007 | +20.3% | 368,910 | 0.0% | 0.10% | -2.1% |
| Q3 2022 | $232,000 | +28.9% | 368,910 | 0.0% | 0.10% | +36.6% |
| Q2 2022 | $180,000 | -41.4% | 368,910 | 0.0% | 0.07% | -18.4% |
| Q1 2022 | $307,000 | -34.5% | 368,910 | 0.0% | 0.09% | -32.0% |
| Q4 2021 | $469,000 | -43.2% | 368,910 | 0.0% | 0.13% | -40.2% |
| Q3 2021 | $826,000 | +10.9% | 368,910 | 0.0% | 0.21% | +5.9% |
| Q2 2021 | $745,000 | -24.1% | 368,910 | 0.0% | 0.20% | -43.4% |
| Q1 2021 | $981,000 | +32.9% | 368,910 | 0.0% | 0.36% | +58.7% |
| Q4 2020 | $738,000 | -29.8% | 368,910 | 0.0% | 0.22% | -42.9% |
| Q3 2020 | $1,051,000 | -8.8% | 368,910 | +23.0% | 0.39% | +41.7% |
| Q2 2020 | $1,152,000 | +25.9% | 300,000 | -18.7% | 0.28% | -23.6% |
| Q1 2020 | $915,000 | -20.6% | 368,910 | +23.0% | 0.36% | +30.9% |
| Q4 2019 | $1,152,000 | +92.3% | 300,000 | 0.0% | 0.28% | +86.6% |
| Q3 2019 | $599,000 | +18.8% | 300,000 | 0.0% | 0.15% | +17.3% |
| Q2 2019 | $504,000 | -10.2% | 300,000 | +41.6% | 0.13% | -9.3% |
| Q1 2019 | $561,000 | +19.4% | 211,872 | +5.9% | 0.14% | +14.8% |
| Q4 2018 | $470,000 | -46.6% | 200,000 | 0.0% | 0.12% | -41.3% |
| Q3 2018 | $880,000 | +10.0% | 200,000 | +30.0% | 0.21% | +5.6% |
| Q2 2018 | $800,000 | +100.0% | 153,874 | +53.9% | 0.20% | +85.8% |
| Q1 2018 | $400,000 | -41.2% | 100,000 | 0.0% | 0.11% | -39.4% |
| Q4 2017 | $680,000 | -16.0% | 100,000 | 0.0% | 0.18% | +78.6% |
| Q3 2017 | $810,000 | +8.0% | 100,000 | 0.0% | 0.10% | -40.2% |
| Q2 2017 | $750,000 | -3.8% | 100,000 | 0.0% | 0.16% | +9.3% |
| Q1 2017 | $780,000 | – | 100,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |